DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,775.00
+105.00 (2.86%)
Nov 20, 2025, 3:30 PM KST
DK Life Science Company Description
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.
It offers active pharmaceutical ingredients (API), injection, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instrument.
The company was founded in 2017 and is based in Seoul, South Korea.
DK Life Science Co., Ltd.
| Country | South Korea |
| Founded | 2017 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Jae Won Park |
Contact Details
Address: Teheran-ro 108-gil 7 Seoul South Korea | |
| Phone | 82 2 3452 7639 |
| Website | dkls.co.kr |
Stock Details
| Ticker Symbol | 303810 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7303810006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae Won Park | Chief Executive Officer |
| Ki-Cheol Kim | Chief Financial Officer |